Dare Ovaprene Study

This 7-month clinical trial is looking at a non-hormonal vaginal ring being developed as a possible new method of birth control. The device is investigational, which means it has not yet been approved by the Food and Drug Administration (FDA) for sale in the United States. The study device is similar in size and shape to FDA-approved devices such as the Nuvaring®. This study is intended to help find out how well the study ring works in preventing sperm from entering a woman’s cervical mucus (the fluid at the opening to the uterus), to understand how easy it is to put in and take out the study ring, and how well the study ring fits.  This study will also analyze how fast the ingredients come out of the study ring and overall safety of the study ring.  To take part in this study, you must be willing to use the study ring and the Caya diaphragm and follow the study visit schedule of 21 visits. 

Eligible participants must be:
•    Healthy women aged 18-50
•    Previously undergone female tubal sterilization
•    Have a regular menstrual period every 24-35 days
•    In a monogamous relationship with a male partner

Eligible participants will receive:

  • Compensation for time and travel (up to $1,925 for completing every part of the study, including 21 study visits and daily electronic diaries)

  • Study tests and exams

 

Click here to fill out the pre-screening questionnaire for this study. 

Study Coordinator: Leah Ingeno, 215-615-0733

© 2017 by Penn Medicine Women's Health Clinical Research Center

University of Pennsylvania, Philadelphia PA

(215) 662-7727